KalVista Pharmaceuticals
KALV
KALV
119 hedge funds and large institutions have $568M invested in KalVista Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 33 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
15% less call options, than puts
Call options by funds: $373K | Put options by funds: $441K
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
32% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 28
Holders
119
Holding in Top 10
3
Calls
$373K
Puts
$441K
Top Buyers
| 1 | +$20.8M | |
| 2 | +$19.4M | |
| 3 | +$15.8M | |
| 4 |
BlackRock
New York
|
+$6.04M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.6M |
Top Sellers
| 1 | -$13.8M | |
| 2 | -$6.83M | |
| 3 | -$6.18M | |
| 4 |
SC
Stempoint Capital
New York
|
-$5M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$4.58M |